WeSearch

STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington

Ed Silverman· ·1 min read · 0 reactions · 0 comments · 14 views
STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington

How a pharma company is soliciting research that can be used to blunt pharma proposed reforms in Washington.

Original article
STAT News · Ed Silverman
Read full at STAT News →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT News

STAT+: Legend Biotech emerged as a rare market winner
STAT News·17
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
STAT News·25
STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says
STAT News·20
STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
STAT News·23
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
STAT News·23
STAT+: Allogene CEO David Chang stepping down
STAT News·27